Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

948 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Imiquimod for actinic keratosis: systematic review and meta-analysis.
Hadley G, Derry S, Moore RA. Hadley G, et al. Among authors: Moore RA. J Invest Dermatol. 2006 Jun;126(6):1251-5. doi: 10.1038/sj.jid.5700264. J Invest Dermatol. 2006. PMID: 16557235 Review.
Nonsteroidal anti-inflammatory drugs, gastroprotection, and benefit-risk.
Moore RA, Derry S, Simon LS, Emery P. Moore RA, et al. Pain Pract. 2014 Apr;14(4):378-95. doi: 10.1111/papr.12100. Epub 2013 Aug 14. Pain Pract. 2014. PMID: 23941628 Free PMC article. Review.
Proton pump inhibitors (PPI) and high-dose histamine-2 receptor antagonists (H2 RA) provided similar gastroprotection, with no conclusive evidence of greater PPI efficacy compared with high-dose H2 RA. ...PPI use at higher doses over longer periods is associated with increased risk of serious adverse events, including fracture; no such evidence was found for H2 RA. ...
Proton pump inhibitors (PPI) and high-dose histamine-2 receptor antagonists (H2 RA) provided similar gastroprotection, with no conclu …
[PubMed: 31107413]
Article details are not available.
Osteoarthritis patients with pain improvement are highly likely to also have improved quality of life and functioning. A post hoc analysis of a clinical trial.
Peloso PM, Moore RA, Chen WJ, Lin HY, Gates DF, Straus WL, Popmihajlov Z. Peloso PM, et al. Among authors: Moore RA. Scand J Pain. 2016 Oct;13:175-181. doi: 10.1016/j.sjpain.2016.07.002. Epub 2016 Aug 10. Scand J Pain. 2016. PMID: 28850528 Clinical Trial.
948 results
Jump to page
Feedback